Clinical Trials
3 trialsNCT02644967 2022-08-03
ILLUMINATE-204
Idera Pharmaceuticals, Inc.
Phase 2 Completed
NCT03865082 2022-02-17
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
Idera Pharmaceuticals, Inc.
Phase 2 Active not recruiting
NCT04126876 2021-04-15
INTRIM
Amsterdam UMC, location VUmc
Phase 2 Recruiting